Clinical trial
A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With…
NCT00268905 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00268905 |
|---|---|
| Title | A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors |
| Official title | A Phase Ib Open-Label, Two-Arm, Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | E7389 + carboplatin AUC 5, E7389 + carboplatin AUC 6, E7389+carboplatin AUC 6 |
| Enrollment | 64 |
| Start date | Oct 1, 2006 |
| Primary completion | Nov 1, 2011 |
| First posted | Dec 23, 2005 |
| Last update posted | Feb 12, 2013 |
| Countries | Austria, India, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: